HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry News: Twinlab Into Resveratrol, Hi-Tech Buys LG Brands

This article was originally published in The Tan Sheet

Executive Summary

Consent decree for Iowa Select; Hi-Tech extends into sports nutrition with LG brands; NBTY adds another Coca-Cola exec to its top management; and more news in brief.

You may also be interested in...



Petition Challenges California Prop 65 Safe Harbor For Lead

In parallel with a lawsuit brought by the Mateel Environmental Justice Foundation, which seeks to eliminate the safe-harbor level for lead under Proposition 65, the Center for Environmental Health has filed a petition with California OEHHA asking for repeal or amendment of lead's maximum allowable dose level.

CHPA’s “Five Moms” Uses Web To Lead Latest Public Service Campaign

The Consumer Healthcare Products Association encourages parents to help stop abuse of cough and cold medicines through online networking, the same means by which young people learn to abuse the substances

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123842

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel